Dergiler / Retina-Vitreus / 2021 / Cilt: 30 - Sayı: 1

Evaluation of Retina and Choroid in Long Term HIV Infection Patients Receiving Antiretroviral Treatment

Sayfa
28–32
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This situation has negative trophic effect on other layers and causes thinning in the macula and choroid.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Purpose:To evaluate changes in macular thickness, ganglion cell inner plexiform and choroid layer of long term Human Immunodefi ciency Virus (HIV) infected patients by optical coherence tomography (OCT) who treated with antiretroviral therapy.
📊
Temel Bulgular & Veri:Matherials and Methods:The study included 50 HIV cases receiving antiretroviral therapy and 50 control groups.
💡
Sonuç & Katkı:This situation has negative trophic effect on other layers and causes thinning in the macula and choroid.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Purpose:To evaluate changes in macular thickness, ganglion cell inner plexiform and choroid layer of long term Human Immunodefi ciency Virus (HIV) infected patients by optical coherence tomography (OCT) who treated with antiretroviral therapy. Matherials and Methods:The study included 50 HIV cases receiving antiretroviral therapy and 50 control groups. Best corrected visual acuity, anterior and posterior segment examinations were performed in both groups. Macula, optic disc and choroid layer measurements were performed with OCT device. Results:The number of males / females in the HIV group is 37/13 and the average age is 42.7 ± 8.3 years, the number of males / females in the control group is 35/15 and the average age is 42.8 ± 8.1 years. No statistically signifi cant difference was found in terms of age and gender in both groups(P = 0.96, P = 0.76 respectively). Avarage choroidal thickness is 267.5 ± 33.1μ in HIV group and 283.3 ± 24.8 μ in control group.(P=0.008) Average macular thickness is 299.8 ± 12.1 μ in HIV group and 316.1 ± 14.4 μ in control group.(P = 0.001) Retinal nerve fi ber thickness is 102.9 ± 10.1 μ in the HIV group and 106.2 ±13.7 μ in the control group.(P = 0.173) Conclusion:HIV patients who received treatment developed thinning in inner retinal layers and choroid layer over time compared to healthy individuals. It suggests that viral particles have degenerative effects on retinal cells by triggering autoimmune reactions. This situation has negative trophic effect on other layers and causes thinning in the macula and choroid.

🔖

Bu Makaleye Atıf Yap

GÜVEN, Y. Z., AKAY, F., AKMAZ, B., DEMİRAL, T., KAPTAN, F. A. (2021). Evaluation of Retina and Choroid in Long Term HIV Infection Patients Receiving Antiretroviral Treatment. Retina-Vitreus, Cilt: 30 - Sayı: 1, 28–32. https://ajindex.com/articles/413571

Kaynakça (14)

  1. Teeraananchai S, Kerr SJ, Amin J, et al. Life expectancy of HIVpositive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med 2017;18:256-66
  2. Robinson MR, Ross ML, Whitcup SM. Ocular manifestations of HIV infection. Curr Opin Ophthalmol 2002;13:397-403
  3. Demirkaya N, Wit F, Schlingemann R, et al. Neuroretinal degeneration in HIV patients without opportunistic ocular infections in the cART era. AIDS Patient Care STDS. 2015;29:519-532
  4. Falkenstein I, Kozak I, Kayikcioglu O, et al. Assessment of retinal function in patients with hiv without infectious retinitis by multifocal electroretinogram and automated perimetry. Retina 2006;26:928-34
  5. Kozak I, Sample PA, Hao J, et al. Machine learning classifi ers detect subtle fi eld defects in eyes of HIV individuals. Trans Am Ophthalmol Soc 2007;105:111-8 6. Shah KH, Holland GN, Yu F, et al. Contrast Sensitivity and Color Vision in HIV-infected Individuals Without Infectious Retinopathy. Am J Ophthalmol 2006;26:928-34
  6. Kozak I, Sasik R, Freeman WR, et al. A Degenerative Retinal Process in HIV-Associated Non-Infectious Retinopathy. PLoS ONE 2013;8(9):e74712
  7. Lagathu C, Cossarizza A, Béréziat V, et al. Basic science and pathogenesis of ageing with HIV: Potential mechanisms and biomarkers. AIDS 2017;31 (suppl 2): S105-19
  8. Freeman WR, Van Natta ML, Jabs D, et al. Vision function in HIV infected individuals without retinitis: report of the studies of ocular complications of AIDS Research Group. Am J Ophthalmol 2008;145:453-62
  9. Jabs DA, Drye L, Van Natta ML, et al. Incidence and long-term outcomes of the human immunodefıciency virus neuroretinal disorder in patients with AIDS. Ophthalmology 2015;122:760-8
  10. Lim MC, Cumberland WG, Minassian SL, et al. Decreased macular leukocyte velocity in human immunodefi ciency virus infected individuals. Am J Ophthalmol 2001;132:711-9
  11. Chen M, Muckersie E, Forrester JV, et al. Immune activation in retinal aging: a gene expression study. Invest Ophthalmol Vis Sci 2010;51:5888-96
  12. Kozak I, Sasik R, Freeman WR, et al. A degenerative retinal process in HIV-associated non-infectious retinopathy. PLoS One 2013;8e74712
  13. Faria E, Arantes TE, Garcia CR, et al. Structural and functional assessment in HIV-infected patients using optical coherence tomography and frequency-doubling technology perimetry. Am J Ophthalmol 2010;149:571-576.e2
  14. Cetin EN, Sayin Kutlu S, Parca O, et al. The thicknesses of choroid, macular segments, p